Boston Scientific Corp
(WBO:BSXC)
€
86
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 70/100 Boston Scientific Corp at Evercore HealthCONx Conference Transcript
Dec 04, 2019 / 04:00PM GMT
Release Date Price:
€38.72
(+0.96%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD
Okay. I think we'll get started here. Thanks everyone for joining us this morning. Vijay Kumar, I cover devices and tools at Evercore. Happy to have with us, Boston Scientific, in their backyard. We have representing the company, Susie Lisa; and Lauren Tengler from the IR team. Susie, Lauren, welcome and thank you for participating.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thank you.
Lauren Tengler
Boston Scientific Corporation - Director of IR
Thank you.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD
So I guess just maybe starting with what happened in 3Q. I mean organic came in really, really strong. I thought, even ex the extra selling days, organic came in really, really strong. Maybe -- was there anything that surprised you guys? I know you guys said all this -- the guidance that's baked in this
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot